News
-
A US District Court has ordered Wockhardt subsidiary Morton Grove Pharmaceuticals “to stop manufacturing and distributing drugs alleged to be adulterated.” The Morton Grove facility manufactured fluticasone propionate nasal sprays in addition to other products.… Read more . . .
-
Dry powder nebulizer developer Nob Hill Therapeutics announced the appointment of Noel Greenberger as its new CEO, replacing interim CEO Yun Li as of September 1, and said that it has received a Department of… Read more . . .
-
SaNOtize announced that it has closed a $24 million Series B funding round led by Horizons Ventures and OurCrowd with proceeds to go towards continued development of the company’s NONS nitric oxide nasal spray. The… Read more . . .
-
According to Lupin, the FDA has approved the company’s ANDA for a generic version of Mylan’s Perforomist formoterol fumarate inhalation solution. Teva launched a generic equivalent in the US in June 2021 after expiration of… Read more . . .
-
Windtree Therapeutics said that it has signed a deal with Lee’s Pharmaceutical and its subsidiary Zhaoke Pharmaceutical giving Lee’s global rights to develop and commercialize Windtree surfactants for any potential indications, including Aerosurf aerosolized KL4 surfactant for… Read more . . .
-
Posted on OINDPnews on August 23, 2022Company: Sandoz Job Description Within our Pharmaceutical Development department, you will be a CMC /Formulation Expert – Scientist / Senior Scientist – (d/f/m) responsible for planning, conducting and evaluating scientific… Read more . . .
-
According to Nuance Pharma, the Chinese Center for Drug Evaluation has approved the company’s IND, allowing for a Phase 3 trial of nebulized ensifentrine, a PDE3/PDE4 inhibitor for the treatment of COPD, in China. The… Read more . . .
-
The US National Institutes of Health (NIH) has published a notice in the Federal Register regarding the availability of intellectual property related to the use of inhaled thrombin inhibitors for the treatment of lung fibrosis… Read more . . .
-
California-based nebulizer developer Respira Technologies has announced that Chief Operating Officer Brian Quigley will replace company founder Mario Danek as CEO, and Danek will take over the role of Chief Technology Officer. Quigley joined the… Read more . . .
-
Pneumagen announced the initiation of a Phase 2 challenge study of its Neumifil multivalent carbohydrate binding module (mCBM) nasal spray, which is the company is developing as a universal treatment for influenza, RSV, and COVID-19. … Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.